![Teva Becomes First Pharmaceutical Company to Execute Sustainability-Linked Bond Tied to Both Climate and Access to Medicine Targets | News Direct Teva Becomes First Pharmaceutical Company to Execute Sustainability-Linked Bond Tied to Both Climate and Access to Medicine Targets | News Direct](https://public.newsdirect.com/788028598/8k5IgnWp.jpg)
Teva Becomes First Pharmaceutical Company to Execute Sustainability-Linked Bond Tied to Both Climate and Access to Medicine Targets | News Direct
![Teva Announces Launch of $4,000,000,000 Offering of Sustainability-linked Senior Notes | Business Wire Teva Announces Launch of $4,000,000,000 Offering of Sustainability-linked Senior Notes | Business Wire](https://mms.businesswire.com/media/20211027005515/en/739014/23/teva_RGB_JPEG.jpg)
Teva Announces Launch of $4,000,000,000 Offering of Sustainability-linked Senior Notes | Business Wire
![Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN](https://cdn.cnn.com/cnnnext/dam/assets/211230154406-teva-pharmaceuticals-file-2021.jpg)
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
![ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business](https://mms.businesswire.com/media/20180914005613/en/678526/5/AJOVY+Image.jpg)
ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business
![Teva Signs an Exclusive WW License Agreement with Modag to Develop Anle138b and Sery433 for Neurodegenerative Disease Teva Signs an Exclusive WW License Agreement with Modag to Develop Anle138b and Sery433 for Neurodegenerative Disease](https://pharmashots.com/public/images/20211125111426_ogImage_50.jpg)
Teva Signs an Exclusive WW License Agreement with Modag to Develop Anle138b and Sery433 for Neurodegenerative Disease
![News of Note—Teva accused of shortcutting plant sale; Sun plant gets only one observation | Fierce Pharma News of Note—Teva accused of shortcutting plant sale; Sun plant gets only one observation | Fierce Pharma](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1554378426/6277208708_7e6607d601_b_0%20%281%29_5.jpg/6277208708_7e6607d601_b_0%20%281%29_5.jpg?VersionId=FQblUlATwAhLgQFGTBwhZAb12olpNVSy)
News of Note—Teva accused of shortcutting plant sale; Sun plant gets only one observation | Fierce Pharma
![Direct Relief, the National Association of Free and Charitable Clinics and Teva Pharmaceuticals Partner to Advance Access to Behavioral Health Services | The National Association of Free & Charitable Clinics Direct Relief, the National Association of Free and Charitable Clinics and Teva Pharmaceuticals Partner to Advance Access to Behavioral Health Services | The National Association of Free & Charitable Clinics](https://nafcclinics.org/wp-content/uploads/2022/06/DR-NAFC-teva-logos-graphic-2.png)
Direct Relief, the National Association of Free and Charitable Clinics and Teva Pharmaceuticals Partner to Advance Access to Behavioral Health Services | The National Association of Free & Charitable Clinics
![Teva Announces Share Pricing Pending Actavis Generics Acquisition | Teva pharmaceuticals, Teva, Pharmaceutical industry Teva Announces Share Pricing Pending Actavis Generics Acquisition | Teva pharmaceuticals, Teva, Pharmaceutical industry](https://i.pinimg.com/736x/9d/fb/a3/9dfba3e1e469623d0a5ce8bd61d3978b--news.jpg)